Neurobiological Technologies to Report First Quarter Financial Results and Host Conference Call on November 8, 2004 RICHMOND, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (NASDAQ:NTII) announced today it will release its first quarter results on November 8, 2004. The company also said that Paul E. Freiman, President and Chief Executive Officer, will host an investor conference call that same day to review the company's financial results and operations. The details for the call are as follows: Live Call: -- Date: Monday, November 8, 2004 -- Time: 10:30 a.m. ET, 7:30 a.m. PT -- Dial-in number: 1-800-289-0569 Webcast of Call: -- A live webcast can be accessed online by going to: http://www.shareholder.com/ntii/medialist.cfm -- The call will be archived and accessible at the same website for one year Telephonic Replay: -- A playback of the conference call will be available from 1:30 p.m. ET through midnight on Monday, November 15, 2004. -- Replay number: 1-888-203-1112 (U.S. and Canada) & 1-719-457-0820 (International) -- Replay access code: 887185 About Neurobiological Technologies, Inc. Neurobiological Technologies, Inc. is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer. DATASOURCE: Neurobiological Technologies, Inc. CONTACT: Paul E. Freiman, President & CEO of Neurobiological Technologies, Inc., +1-510-262-1730; or Cheryl Schneider, VP, Investor Relations of Porter, Le Vay & Rose, Inc., +1-212-564-4700, for Neurobiological Technologies, Inc. Web site: http://www.ntii.com/

Copyright

Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Neurobiological Charts.
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Neurobiological Charts.